Evidence map›Paper›PMID 28758697›Full record

ReviewBritish journal of clinical pharmacology2017

Renal toxicity and chemotherapy in children with cancer.

Antonio Ruggiero, Pietro Ferrara, Giorgio Attinà, Daniela Rizzo, Riccardo Riccardi

Abstract readReview
In one paragraph

Review in British journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Effect of truncating blood sampling in measuring glomerular filtration rate.American journal of nuclear medicine and molecular imaging · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Antonio RuggieroDivision of Paediatric Oncology, Catholic University of Rome, Rome, Italy.ORCID 0000-0002-6052-3511
Pietro FerraraDivision of Paediatric Oncology, Catholic University of Rome, Rome, Italy.
Giorgio AttinàDivision of Paediatric Oncology, Catholic University of Rome, Rome, Italy.
Daniela RizzoDivision of Paediatric Oncology, Catholic University of Rome, Rome, Italy.
Riccardo RiccardiDivision of Paediatric Oncology, Catholic University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical use of antineoplastic drugs can be limited by different drug-induced toxicities. Of these, renal dysfunction may be one of the most troublesome in that it can be cumulative and in general is only partially reversible with the discontinuation of the treatment. Renal toxicity may be manifested as a reduction of the glomerular filtration rate, electrolyte imbalances, or acute renal failure. Careful assessment of renal function has to be performed taking into account that the impairment of renal function is initially silent and only later may be clinically dramatic. When clinically indicated, the reduction or, in cases of severe nephrotoxicity, the suspension of chemotherapy should be considered to avoid the progressive deterioration of the compromised glomerular and/or tubular function.

Indexed as

Age of OnsetAntineoplastic AgentsChildChild, PreschoolCisplatinHumansIfosfamideIncidenceInfantKidneyKidney DiseasesKidney Function TestsNeoplasmsRisk FactorsTreatment OutcomeAntineoplastic AgentsCisplatinIfosfamidechemotherapychildrennephrotoxicity

Identifiers

PMID28758697
PMCPMC5698594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.